21 Results

People

  1. Stefanski
    Stefanski
  2. Wang
    Wang
  3. Riviere
    Riviere
  4. Sadelain
    Sadelain
  5. Borquez-Ojeda
    Borquez-Ojeda
  6. Bartido
    Bartido
  7. Brentjens
    Brentjens
  8. Davila
    Davila
  9. Park
    Park
  10. Olszewska
    Olszewska

Groups

  1. Center for Hematologic Malignancies (21)
  2. Department of Medicine (21)
  3. GSK Faculty (21)
  4. Hematologic Malignancies Research (21)
  5. Hematologic Malignancies, Division of (21)
  6. Molecular Pharmacology and Chemistry Program Faculty (20)
  7. Sloan Kettering Institute Faculty (20)
  8. Adult Leukemia (13)
  9. Pediatrics, Department of (6)
  10. Stem Cell Transplantation and Cellular Therapy Service (6)
  1. "Hematologic Malignancies Research"
  2. "Xiuyan Wang"
  3. "Jolanta Stefanski"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (21)
  2. Department of Medicine (21)
  3. GSK Faculty (21)
  4. Hematologic Malignancies Research (21)
  5. Hematologic Malignancies, Division of (21)
  6. Molecular Pharmacology and Chemistry Program Faculty (20)

More Groups

People
  1. Isabelle Riviere (21)
  2. Jolanta Stefanski (21)
  3. Xiuyan Wang (21)
  4. Michel Sadelain (20)
  5. Oriana Borquez-Ojeda (15)
  6. Shirley Bartido (14)

More People

Years
  1. 2021 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (3)

More Years

Publications
  1. Blood (6)
  2. Molecular Therapy (6)
  3. Cancer Research (2)
  4. Journal of Clinical Oncology (2)
  5. Science Translational Medicine (2)
  6. Gene Therapy (1)

More Publications

Publishers
  1. Nature Publishing Group (8)
  2. American Society of Hematology (6)
  3. American Association for Cancer Research (2)
  4. American Association for the Advancement of Science (2)
  5. American Society of Clinical Oncology (2)
  6. Mary Ann Liebert, Inc (1)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial
    Meeting Abstract

    Abujarour, R.; Lai, Y. S.; Pribadi, M.; Lee, T.; Robinson, M.; Ruller, C.; Van der Stegen, S.; Wang, X.; Stefanski, J.; Zhen, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CAR-T cell manufacturing with CliniMACS Prodigy
    Meeting Abstract

    Wang, X.; Stefanski, J.; Chaudhari, J.; Hall, M.; Thummar, K.; Zhao, Z.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • Selection and purification of CD34+ cells from cryopreserved cord blood units using CliniMACS Plus and CliniMACS Prodigy
    Meeting Abstract

    Wang, X. Y.; Stefanski, J.; Hack, A.; He, Q.; Boyle, R.; Barker, J.; Scandura, J.; Rafii, S.; Sadelain, M.; Riviere, I.
    Molecular Therapy (2017)

    Fulltext@MSK | Save
  • Evaluation of Miltenyi ExpAct and TransAct CD3/28 beads for CAR-T cell manufacturing
    Meeting Abstract

    Wang, X.; Qu, J.; Stefanski, J.; Borquez-Ojeda, O.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Rivière, I.
    Molecular Therapy (2016)

    Fulltext@MSK | Save
  • Comparison of CTS™ Dynabeads® CD3/CD28, Miltenyi TransAct CD3/28 and ExpAct Beads for large-scale CAR T cell manufacturing
    Meeting Abstract

    Wang, X.; Stefanski, J.; Borquez-Ojeda, O.; Qu, J.; Hack, A.; He, Q.; Wasielewska, T.; Du, F.; Sadelain, M.; Riviere, I.
    Human Gene Therapy (2015)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Sadelain, M.; Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; Stefanski, J.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save